Mirtazapine Teva

Mirtazapine, the active ingredient in Mirtazapine Teva, is a tetracyclic antidepressant presented as an oral tablet for oral use. It is indicated for the treatment of major depressive disorder in adult patients, helping to improve mood and functional outcomes. It is available in dosage strengths that allow flexible titration according to clinical response.

GNH USA supplies Mirtazapine Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide, ensuring quality‑assured products that meet regulatory standards across diverse markets.

Mirtazapine is a tetracyclic antidepressant used in the management of depressive disorders. - Major depressive disorder: alleviates depressive symptoms and improves overall mood and functioning.

Mirtazapine may cause a range of adverse reactions.

Common Side Effects: - Sedation: feeling unusually sleepy or drowsy. - Increased appetite: heightened desire for food, often leading to weight gain. - Weight gain: noticeable increase in body weight. - Dry mouth: reduced salivation causing oral discomfort. - Constipation: infrequent or difficult bowel movements. - Dizziness: sensation of light‑headedness or imbalance.

Serious or Rare Side Effects: - Agranulocytosis: severe reduction in white blood cells. - Severe neutropenia: markedly low neutrophil count. - Seizures: convulsive episodes. - Hypersensitivity reactions: rash, swelling, or anaphylaxis. - Suicidal thoughts: emergence or worsening of suicidal ideation. - Hepatotoxicity: potential liver injury.

Before prescribing Mirtazapine, clinicians should consider several safety aspects. - Monitor depression: watch for worsening mood or emergence of suicidal thoughts. - Hepatic impairment: use cautiously in patients with liver dysfunction. - Discontinuation: avoid abrupt stopping to reduce withdrawal risk. - Elderly patients: start at low dose and monitor for sedation. - Pregnancy and lactation: safety not established; discuss risks with a healthcare provider. - Store at room temperature: keep in the original packaging, protect from moisture and heat.

Mirtazapine can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - CNS depressants (e.g., benzodiazepines, opioids): enhanced sedation and respiratory depression. - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): increased mirtazapine plasma levels.

Moderate Interactions (Monitor Closely): - Other antidepressants (SSRIs, SNRIs): potential for serotonin syndrome. - Alcohol: may intensify sedative effects. - Antihistamines: additive drowsiness. - Carbamazepine: may reduce mirtazapine effectiveness. - Warfarin: monitor INR for possible anticoagulant effect changes.